Journal article icon

Journal article

A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors

Actions


Authors


Expand authors...
Journal:
Cancer Chemotherapy and Pharmacology
Pages:
1-10
Publication date:
2011-01-01
EISSN:
1432-0843
ISSN:
0344-5704
URN:
uuid:b47eda90-468f-4feb-b6db-4ce12d0ee8d5
Source identifiers:
186435
Local pid:
pubs:186435

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP